97326-38-0

Basic information

• Product Name: 5-Hydroxy-1-(phenylmethyl)-1H-1,2,3-triazole-4-carboxylic Acid
• Synonyms: 5-Hydroxy-1-(phenylmethyl)-1H-1,2,3-triazole-4-carboxylic Acid
• CAS NO: 97326-38-0
• Molecular Weight: 219.2
• Mol File: 97326-38-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-Hydroxy-1-(phenylmethyl)-1H-1,2,3-triazole-4-carboxylic Acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Hydroxy-1-(phenylmethyl)-1H-1,2,3-triazole-4-carboxylic Acid(97326-38-0)
• EPA Substance Registry System: 5-Hydroxy-1-(phenylmethyl)-1H-1,2,3-triazole-4-carboxylic Acid(97326-38-0)

Safety Data

• Hazardous Substances Data: 97326-38-0(Hazardous Substances Data)

Upstream product

• 622-79-7 benzyl azide 
• 94158-08-4 Ethyl 1-phenylmethyl-5-hydroxy-1,2,3-triazole-4-carboxylate 

Downstream Products

• 97326-41-5 1-benzyl-1H-1,2,3-triazol-5-ol 
• 1619971-97-9 methyl 4-[(1-benzyl-1H-1,2,3-triazol-5-yl)oxy]butanoate 
• 106157-53-3 3-Benzyl-10-[4-(4-fluoro-phenyl)-piperazin-1-yl]-3H-4-oxa-1,2,3,9-tetraaza-benzo[f]azulene 
• 106157-52-2 3-Benzyl-10-(4-benzyl-piperazin-1-yl)-3H-4-oxa-1,2,3,9-tetraaza-benzo[f]azulene 
• 106157-54-4 3-Benzyl-7-methyl-10-(4-methyl-piperazin-1-yl)-3H-4-oxa-1,2,3,9-tetraaza-benzo[f]azulene 
• 106157-51-1 3-benzyl-10-(4-methyl-1-piperazinyl)-3H-1,2,3-triazolo<4,5-b><1,5>benzoxazepine 
• 106157-37-3 1-Benzyl-5-chloro-1H-[1,2,3]triazole-4-carboxylic acid (2-hydroxy-5-methyl-phenyl)-amide 
• 106157-42-0 7-Methyl-3-(phenylmethyl)-3H-1,2,3-triazolo<4,5-b><1,5>benzoxazepin-10(9H)-one 
• 106157-36-2 1-Benzyl-5-chloro-1H-[1,2,3]triazole-4-carboxylic acid (2-hydroxy-phenyl)-amide 
• 106157-41-9 3-(Phenylmethyl)-3H-1,2,3-triazolo<4,5-b><1,5>-benzoxazepin-10(9H)-one 
• 96938-79-3 5-Chloro-1-(phenylmethyl)-1H-1,2,3-triazole-4-carbonyl chloride 

Relevant articles and documents

Bicyclic Pyrimidine Compounds

The present invention provides compounds of the Formula I: wherein X is a bond or CH2; R is selected from the group consisting of R1 and R2 are each independently selected from the group consisting of CH and N; R3 is H or CH3; R4 is H or CH3; L is selected from the group consisting of —O(CH2)3—, —C(O)NH(CH2)2—, —CH2C(O)NH(CH2)2—, —(CH2)3N(C(O)CH3)CH2—, —(CH2)2N(C(O)CH3)CH2—, —(CH2)3NH—, (CH2)2OCH2—, —(CH2)4—, —(CH2)2NHCH2—, —(CH2)3O—, and —CH2O(CH2)2—; or a pharmaceutically acceptable salt thereof. Compounds of this invention are autotaxin inhibitors.